Education
About Us
Working with TipRanks
Follow Us
JENNIFER CARVER Insider Profile
4 Followers
JENNIFER CARVER, COO at La Jolla Pharma, holds 73.36K shares in Revelation Biosciences (Ticker: REVB), holds 14.05K shares in La Jolla Pharma (Ticker: LJPC).
Profitable Transactions
0 out of 5 Profitable Transactions
Average Return
-45.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of JENNIFER CARVER's holdings
Insider Roles
Director
Roles that JENNIFER CARVER holds in companies
Most Profitable Insider Trade
Stock:
La Jolla Pharma
(LJPC)
(LJPC)
Rating:Informative Buy
Date:Mar 06, 2017 - Mar 06, 2018
Return:-4.40%
The most profitable trade made by JENNIFER CARVER
JENNIFER CARVER's Trading History
La Jolla Pharma
Mar 04, 2019
―
Uninformative Buy
1.12K
$87.38K
Revelation Biosciences
Jan 12, 2026
Director
Uninformative Buy
37.78K
$66.39K
List of latest transactions for each holding click on a transaction to see JENNIFER CARVER's performance on stock
You May Also Like
JENNIFER CARVER insider profile FAQ
What is the percentage of profitable transactions made by JENNIFER CARVER?
The percentage of profitable transactions made by JENNIFER CARVER is 0%.
What is the average return per transaction made by JENNIFER CARVER?
The average return per transaction made by JENNIFER CARVER is -45.20%.
What stocks does JENNIFER CARVER hold?
JENNIFER CARVER holds: LJPC, REVB stocks.
What was JENNIFER CARVER’s latest transaction?
JENNIFER CARVER latest transaction was an Uninformative Buy of $37.78K.
What was JENNIFER CARVER's most profitable transaction?
JENNIFER CARVER’s most profitable transaction was an Informative Buy of LJPC stock on March 6, 2017. The return on the trade was -4.40%.
What is JENNIFER CARVER's role in La Jolla Pharma?
JENNIFER CARVER's role in La Jolla Pharma is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.